Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Oncopeptides Total Assets (Quarterly): 27.02M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 27.02M |
| June 30, 2023 | 32.78M |
| March 31, 2023 | 30.61M |
| December 31, 2022 | 36.97M |
| September 30, 2022 | 42.74M |
| June 30, 2022 | 14.60M |
| March 31, 2022 | 28.27M |
| December 31, 2021 | 48.57M |
| September 30, 2021 | 94.10M |
| June 30, 2021 | 192.52M |
| March 31, 2021 | 80.51M |
| December 31, 2020 | 115.62M |
| September 30, 2020 | 147.41M |
| June 30, 2020 | 111.77M |
| Date | Value |
|---|---|
| March 31, 2020 | 66.43M |
| December 31, 2019 | 106.32M |
| September 30, 2019 | 116.95M |
| June 30, 2019 | 75.96M |
| March 31, 2019 | 90.53M |
| December 31, 2018 | 43.84M |
| September 30, 2018 | 62.19M |
| June 30, 2018 | 71.13M |
| March 31, 2018 | 88.62M |
| December 31, 2017 | 58.67M |
| September 30, 2017 | 65.01M |
| June 30, 2017 | 70.48M |
| December 31, 2016 | 6.136M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.60M
Minimum
Jun 2022
192.52M
Maximum
Jun 2021
76.06M
Average
71.20M
Median
Total Assets (Quarterly) Benchmarks
| Abliva AB | 8.692M |
| Karolinska Development AB | 118.29M |
| Calliditas Therapeutics AB | 184.69M |
| Olink Holding AB | 602.25M |
| BioInvent International AB | 124.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.80M |
| Shareholders Equity (Quarterly) | 12.22M |
| Debt to Equity Ratio | 0.8095 |
| Current Ratio | 6.678 |
| Net Debt Paydown Yield | -2.57% |